B. Parasuraman

发表

Optimal recall periods for patient-reported outcomes: challenges and potential solutions.

D. Stull, N. Leidy, B. Parasuraman, 2009, Current medical research and opinion.

Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.

E. Kerwin, B. Parasuraman, Christopher J. Miller, 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Can managed care organizations partner with manufacturers for comparative effectiveness research?

G. de Lissovoy, B. Parasuraman, B. Luce, 2008, The American journal of managed care.

Pediatric Asthma: Improving Management to Reduce Cost of Care

B. Parasuraman, M. Mellon, 2004, Journal of managed care pharmacy : JMCP.

Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancer.

B. Parasuraman, D. Cella, D. Eton, 2008, Clinical lung cancer.

Baseline Characteristics and Secondary Medication Adherence Patterns Among Patients Receiving Tafamidis Prescriptions: A Retrospective Analysis Using a National Specialty Pharmacy Dispensing Database

B. Parasuraman, J. Kemner, Andrew Peterson, 2022, Patient preference and adherence.

B. Parasuraman, L. O’Dowd, W. Berger, 2008 .

PATIENT SATISFACTION WITH BUDESONIDE AND FORMOTEROL IN ONE PRESSURIZED METERED-DOSE INHALER IN PATIENTS WITH ASTHMA

B. Parasuraman, Paula Martin, J. Baker, 2007 .

An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia.

B. Parasuraman, R. R. Williams, B. Rittenhouse, 2000, The American journal of managed care.

Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers.

B. Parasuraman, W. Sokol, H. Nelson, 2004, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

Development and validation of an onset of effect questionnaire for patients with asthma.

N. Leidy, B. Parasuraman, D. Patrick, 2008, Allergy and asthma proceedings.

Optimal recall periods for patient-reported outcomes: challenges and potential solutions

D. Stull, N. Leidy, B. Parasuraman, 2009, Current medical research and opinion.

EGFR Mutation Testing in Patients with Advanced Non-Small Cell Lung Cancer: A Comprehensive Evaluation of Real-World Practice in an East Asian Tertiary Hospital

B. Parasuraman, E. Guallar, Y. Shim, 2013, PloS one.

Real world impact of epidermal growth factor receptor mutation status on treatment patterns in patients with non-small cell lung cancer.

B. Parasuraman, E. Guallar, Y. Shim, 2013, Lung cancer.

Pain in castration-resistant prostate cancer with bone metastases: a qualitative study

Adam Gater, B. Parasuraman, E. Piault, 2011, Health and quality of life outcomes.

The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children.

B. Parasuraman, Christopher J. Miller, L. O’Dowd, 2010, Allergy and asthma proceedings.

Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler.

B. Parasuraman, R. Boggs, L. O’Dowd, 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids.

N. Leidy, B. Parasuraman, Christopher J. Miller, 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma

B. Parasuraman, Christopher J. Miller, H. Nelson, 2008, Current medical research and opinion.

Factors influencing patient decisions about the use of asthma controller medication.

B. Parasuraman, Z. Tran, B. Bender, 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Budesonide Turbuhaler delivered once daily improves health-related quality of life and maintains improvements with a stepped-down dose in adults with mild to moderate asthma.

T. Casale, B. Parasuraman, H. Nelson, 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Patient-reported outcomes: instrument development and selection issues.

Charles S Cleeland, Ralph R Turner, Alexandra L Quittner, 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Total and Component Health Care Costs in a Non-Medicare HMO Population of Patients With and Without Type 2 Diabetes and With and Without Macrovascular Disease

J. L. Wall, B. Parasuraman, J. Sherman, 2006, Journal of managed care pharmacy : JMCP.

Once-daily budesonide inhalation powder (Pulmicort Turbuhaler®) improves health-related quality of life in adults previously receiving inhaled corticosteroids

B. Parasuraman, F. Hampel, B. Liljas, 2004, Advances in therapy.

PPA_A_352332 1115..1129

B. Parasuraman, J. Kemner, Andrew Peterson, 2022 .

Electronic Versus Paper Questionnaires: A Further Comparison in Persons with Asthma

B. Parasuraman, D. Bushnell, D M Bushnell, 2003, The Journal of asthma : official journal of the Association for the Care of Asthma.

Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.

W. Busse, B. Parasuraman, M. Goldman, 2008, The Journal of allergy and clinical immunology.

Baseline characteristics and secondary medication adherence among Medicare patients diagnosed with transthyretin amyloid cardiomyopathy and/or receiving tafamidis prescriptions: A retrospective analysis of a Medicare cohort

B. Parasuraman, A. Peterson, J. Kemner, 2022, Journal of managed care & specialty pharmacy.

Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities.

B. Parasuraman, C. Roberts, C. Leibman, 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Comparison of Patient-Reported Outcomes During Treatment With Adjustable- and Fixed-Dose Budesonide/Formoterol Pressurized Metered-Dose Inhaler Versus Fixed-Dose Fluticasone Propionate/Salmeterol Dry Powder Inhaler in Patients With Asthma

B. Parasuraman, D. Patrick, M. Goldman, 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

Budesonide turbuhaler delivered once daily improves health-related quality of life in adult patients with non-steroid-dependent asthma.

B. Parasuraman, W. Lumry, B. Liljas, 2003, Allergy and Asthma Proceedings.

Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.

B. Parasuraman, Christopher J. Miller, K. Murphy, 2003, Pediatrics.